Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ESR1 peptide-pulsed DC1 vaccine |
| Trade Name | |
| Synonyms | Autologous native ESR1-pulsed alternating with mutated ESR1-pulsed DC1 Vaccine |
| Drug Descriptions |
ESR1 peptide-pulsed DC1 vaccine comprises autologous dendritic cells pulsed with wild-type ESR1 or mutant ESR1, which are delivered in an alternating manner and potentially induce a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing ESR1 (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C212039 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Elacestrant + ESR1 peptide-pulsed DC1 vaccine | ESR1 peptide-pulsed DC1 vaccine Elacestrant | 0 | 1 |
| ESR1 peptide-pulsed DC1 vaccine | ESR1 peptide-pulsed DC1 vaccine | 0 | 0 |